back to Australia directory
australia clinical guidance

Long COVID

A detailed Australian summary of long covid, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. NSW ACI long COVID guide is used as an explicitly New South Wales implementation source. Verify the corresponding state or territory pathway before acting.

Scope

Confirm the timing and pattern after SARS-CoV-2 while considering reinfection and alternative cardiopulmonary, neurological, endocrine and mental-health diagnoses. Assess fatigue, post-exertional symptom exacerbation, breathlessness, chest symptoms, cognition, autonomic symptoms, sleep and functional or occupational impact. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:NSW ACI long COVID guide

The Bottom Line

  • Confirm the timing and pattern after SARS-CoV-2 while considering reinfection and alternative cardiopulmonary, neurological, endocrine and mental-health diagnoses.
  • Assess fatigue, post-exertional symptom exacerbation, breathlessness, chest symptoms, cognition, autonomic symptoms, sleep and functional or occupational impact.
  • Use lying and standing measurements when orthostatic intolerance is reported and support fluid or compression advice only after contraindication review.
  • Use symptom-directed examination and tests rather than a fixed investigation panel, and identify rehabilitation that will not provoke post-exertional deterioration.
sources for this section:NSW ACI long COVID guide

Practical clinical workflow

1

Topic-specific assessment action

Confirm the timing and pattern after SARS-CoV-2 while considering reinfection and alternative cardiopulmonary, neurological, endocrine and mental-health diagnoses.
2

Topic-specific diagnostic action

Use symptom-directed examination and tests rather than a fixed investigation panel, and identify rehabilitation that will not provoke post-exertional deterioration.
3

Topic-specific management action

Set collaborative goals, validate fluctuating disability and coordinate pacing, rehabilitation, workplace or education support and specialist referral by phenotype.
4

Topic-specific follow-through

Breathing-pattern disorder may benefit from respiratory physiotherapy even when routine imaging and spirometry are normal.
sources for this section:NSW ACI long COVID guide

Safety boundaries and escalation

  • Urgently assess new hypoxia, chest pain, syncope, focal neurology, severe mental-health risk, thromboembolism or another acute deterioration rather than attributing it to long COVID.
  • Avoid attributing all distress to anxiety; mental-health treatment and investigation of physical symptoms can proceed together.
sources for this section:NSW ACI long COVID guide

Implementation

NSW ACI long COVID guide is a New South Wales source. It supplies an Australian implementation example, not a national rule. Confirm the equivalent pathway, referral destination and medicine policy in the patient鈥檚 state or territory. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:NSW ACI long COVID guide

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:NSW ACI long COVID guide

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. NSW Agency for Clinical InnovationClinical practice guide for assessment and management of adults, children and young people with symptoms of long COVID2026 clinical practice guide 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.